Betadine, Vaginal-Ovula

7680385960019 CH-38596 Suppositorien

Associated product:

BETADINE ovules vaginaux 14 pce
Betadine, Vaginal-Ovula
Betadine, Vaginal-Ovula
Betadine, Vaginal-Ovula
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Suppositorien
Galenic form
Suppositorien
Galenic group
Suppositorien

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/12/2024
Patient information leaflet
Français
25/12/2024
Patient information leaflet
Italien
25/12/2024
Summary of Product Characteristics
Allemand
25/12/2024
Summary of Product Characteristics
Français
25/12/2024
Summary of Product Characteristics
Italien
25/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
macrogolum 4000
- Substance HNIDK
macrogolum 1500
- Substance HNIDK

Authorization holder

iNova Pharmaceuticals (Switzerland) AG

6300 Zug

Authorization information

Swissmedic authorization number
38596
Drug name
Betadine, Vaginal-Ovula
Galenic form
VAGZ
ATC Code
G01AX11
Authorization status
Z
Dispensing category
B
First authorization
28/01/1975
Authorization expiration date
31/12/9999
IT Number
09.03.0.
Domain
Human medicine
Field of application
Vaginal-Infektionen

Package details

Description (FR)
BETADINE ovules vaginaux 14 pce
Description (DE)
BETADINE Vaginal-Ovula 14 Stk
Market launch
28/01/1975
Narcotic (BTM)
No

Other package sizes (1)

BETADINE ovules vag 14 pce
None None
GTIN: 7680385960125
Not in V1